Skip to main content

Table 3 association between FTO (rs9939609) polymorphism and Clinical characteristics of subjects

From: The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study

Characteristics FTO (rs9939609) Genotypes P
TT(n = 67) AT(n = 104) AA(n = 26)  
Age, years, mean ± S.D 46.3 ± 8.6 44.02 ± 9.8 45.65 ± 10.7 0.29 a
BMI, Kg/m2, mean ± S.D 31 ± 8 31.37 ± 8.2 33.1 ± 7.2 0.51a
Waist (cm),mean ± S.D 103.2 ± 20.2 103.3 ± 20.1 106.8 ± 16.1 0.69a
TC (mg/dl), mean ± S.D 178.3 ± 33.1 172.4 ± 36.2 163.4 ± 38 0.18 a
TAG (mg/dl), mean ± S.D 148.3 ± 73.8 138.6 ± 71.9 136 ± 58 0.62 a
HDL-C (mg/dl), mean ± S.D 43.2 ± 10.7 42.2 ± 8 37 ± 8.5 0.01 a
LDL-C (mg/dl), mean ± S.D 105.4 ± 29.7 102.5 ± 32.7 99.3 ± 27.7 0.67 a
FPG (mg/dl), median(min-max) 108(69–323) 100.5(60–361) 138.5(76–350) 0.2 b
FSI(μIU/mL), median(min-max) 10.5(2.4–30) 9.73(1–30.3) 12.2(2.9–29.3) 0.59 b
HOMA-IR,median(min-max) 3.1 (0.6–23.9) 2.4 (0.2–20.45) 3.6 (1.29–20.46) 0.28 b
QUICKI, mean ± S.D 0.33 ± 0.042 0.34 ± 0.06 0.32 ± 0.034 0.11 a
AST(IU/mL), median(min-max) 15(4–53) 12.5(4–60) 17(8–58) 0.19 b
ALT(IU/mL), median(min-max) 14(4–60) 11(4–57) 15.5(6–58) 0.02 b
  1. BMI Body mass index, WC Waist circumference, T.C Total cholesterol, TAG Triacylglycerol, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, FPG Fasting plasma glucose, FSI Fasting serum insulin
  2. aone way ANOVA test, two-sided p value >0.05 non-significant
  3. b Kruskal-Wallis test, two-sided p value >0.05 non-significant